InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Clinical Trial Imaging Services Market- by Service Types (Clinical Trial Design & Consultation Services, Reading &, Operational Imaging Services, Project & Data Management Services, and Other Service Types), Therapeutic Areas (Oncology, Neurology, Endocrinology, Analytical Services Cardiology, Gastroenterology, and Other Therapeutic Area), End-Users (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, and Academic & Government Research Institutes), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”
According to the latest research by InsightAce Analytic, the global Clinical Trial Imaging Services Market Size is valued at 1155.6 Million in 2022 and is predicted to reach 1901.2 Million by the year 2031 at a 5.8 % CAGR during the forecast period for 2023-2031.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1023
Clinical trial imaging services encompass a suite of offerings provided by contract research organizations (CROs) to support imaging activities in clinical trials. These services are essential for pharmaceutical, medical device, biotechnology, and related industries that rely on imaging for diagnostic and therapeutic evaluations.
The primary driver of market expansion is the growing trend toward outsourcing clinical trial imaging operations, as companies increasingly recognize the value of leveraging external expertise. Advancements in medical imaging technology and the heightened adoption of imaging in clinical trials—spurred by the rising prevalence of chronic diseases that demand innovative treatment options—are also fueling growth.
North America is anticipated to be the major contributor to the Clinical Trial Imaging Services market over the forecast years. This is attributable to the increased use of imaging as an outcome in clinical trials, which encourages sponsors to outsource these services to reduce associated costs. Additionally, the presence of significant competitors like Parexel International, Biospective, Inc., ERT Clinical, and Intrinsic Imaging LLC makes clinical trial imaging services easily accessible, which in turn spurs the market’s expansion in the area.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1023
Major market players operating in the Clinical Trial Imaging Services market include
Calyx, Biospective Inc., Bioclinica Inc., Ert Clinical, Median Technologies, Proscan Imaging, Ixico Plc, Imaging Endpoints, Intrinsic Imaging, Llc, Micron, Inc., Medpace, Inc., Pharmtrace, Icon Plc., and other Prominent Player.
Recent collaborations and agreements in the market:
- In May 2021, IXICO Plc. (UK) and biopharmaceutical client IXICO entered into a contract to provide neuroimaging services for a Phase III clinical trial.
- In February 2021, HepaFat AI software from Resonance Health Ltd. (Australia) acquired CE mark approval for market commercialization in Europe.
- In February 2021, PRA Health Science (US) was purchased by ICON Plc. (Ireland) for expanding its clinical research and global healthcare intelligence operations.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1023
Market Segments
Global Clinical Trial Imaging Services Market, by Service Types, 2023-2031 (Value US$ Mn)
- Clinical Trial Design & Consultation Services
- Reading & Analytical Services
- Operational Imaging Services
- Project & Data Management Services
- Other Service Types
Global Clinical Trial Imaging Services Market, by Therapeutic Areas, 2023-2031 (Value US$ Mn)
- Oncology
- Neurology
- Endocrinology
- Cardiology
- Gastroenterology
- Other Therapeutic Area
Global Clinical Trial Imaging Services Market, by End-Users, 2023-2031 (Value US$ Mn)
- Pharmaceutical & Biotechnology Companies
- Medical Device Manufacturers
- Academic & Government Research Institutes
Global Clinical Trial Imaging Services Market, by Region, 2023-2031 (Value US$ Mn)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America Clinical Trial Imaging Services Market, by Country, 2023-2031 (Value US$ Mn)
- S.
- Canada
Europe Clinical Trial Imaging Services Market, by Country, 2023-2031 (Value US$ Mn)
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific Clinical Trial Imaging Services Market, by Country, 2023-2031 (Value US$ Mn)
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America Clinical Trial Imaging Services Market, by Country, 2023-2031 (Value US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa Clinical Trial Imaging Services Market, by Country, 2023-2031 (Value US$ Mn)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Get More Information: @
https://www.insightaceanalytic.com/report/global-clinical-trial-imaging-services-market/1023
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
